Return to the home page. top banner right
top banner bottom
Click to search.
members
Login:
Password:
Click to login
Click for Log In Help
Click to Join the Society
 
Learn more about the Society's Sudden Cardiac Arrest Awareness Campaign
 
 
 
Click for the Heart Rhythm Foundation
Click for the IBHRE (formerly NASPExAM)
Click for Professional Education
Click for Health Policy
 
 
 
 
 
Click for Clinical Guidance
Click for Research
Click for News & Information
Click for Scientific Sessions
Click for the HRS Calendar
Click for the HeartRhythm Journal
Click for the HRS Store
Click to Find a Specialist
Click for Patient Information
Click for About HRS
Click for Membership
Click for Career Center
Click for the AF 360° Resource Center
Click for the SCA 360° Resource Center
titlelines FDA and Thomas Medical Products Inc.'s Class I Recall
The FDA and Thomas Medical Products Inc. notified healthcare professionals of a Class I Recall of certain lots of the Safesheath CSG Coronary Sinus Guide Hemostatic Introducer System with Infusion Sideport.
content_line
Safesheath CSG Coronary Sinus Guide Hemostatic Introducer System with Infusion Sideport by Thomas Medical

On February 4, 2010, the U.S. Food and Drug Administration (FDA) and Thomas Medical Products Inc. notified health care professionals of a Class I Recall of certain lots of Safesheath CSG Coronary Sinus Guide Hemostatic Introducer System with Infusion Sideport, tube-like devices placed into blood vessels to insert pacing or defibrillator wires and catheters into blood vessels. The sheath tip may break off and separate while the sheath is inside a blood vessel. If this occurs, the sheath tip could move through the blood vessel into organs such as the lungs and heart or, less commonly, into arteries. From there, the broken tip could cause a blockage anywhere, including the brain or heart, leading to permanent injury, such as a stroke or heart attack, or even death.

Any adverse events that may be related to use should be reported to the FDA's MedWatch Safety Information and Adverse Event Reporting Program online with the MedWatch Online Voluntary Reporting Form), by phone 1 (800) 332-1088 or fax 1 (800) FDA-0178. Individuals can also report  adverse events to the FDA by returning the postage-paid FDA form 3500 (obtain forms by visiting the FDA's Download Forms web page) and mailing the form to the address on the pre-addressed form.

Read the complete MedWatch 2010 Safety summary, which includes a link to the FDA recall notice.

Click to Email Page. Click to Print Page.
Click to Contact Us.Click for the Site Map.
© Heart Rhythm Society | 1400 K St. NW, Suite 500 | Washington DC 20005 | (202) 464-3400 | Fax: (202) 464-3401 | Privacy Policy